Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 18 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Sacral resection provides local control of recurrent rectal cancer

Sacrectomy for rectal cancer is a high-risk procedure that can achieve clear resection margins with good local control, and low mortality in select patients, finds August's issue of Diseases of the Colon & Rectum.

News image

fiogf49gjkf04

Composite sacropelvic resection for locally advanced recurrent rectal cancer is a high-risk procedure that benefits select patients.

Dr Genevieve Melton and colleagues from New York reviewed a recent institutional experience to evaluate case selection, morbidity, and outcomes for these patients.

Between 1987 and 2004, 29 patients underwent composite resection for recurrent locoregional rectal cancer.

The research team evaluated clinicopathologic indicators as indicators of survival by log-rank test and Cox proportional hazards model.

The researchers reported that 10 patients received radiotherapy with their previous surgery, 17 before sacrectomy, and 12 received intraoperative therapy.

Sacral resections were performed at S2/S3 or S4/S5 using anterior or combined anterior-posterior approach, with adherence to or cortical invasion in the sacrum.

The researchers found the majority of those who had undergone previous abdominoperineal resection had total exenteration.

Most patients who had undergone a previous sphincter-preserving procedure had abdominoperineal resection and none had exenteration.

The team noted that pedicle flaps were used often.

A median of 5 units of blood was given intraoperatively.

The 2-year recurrence rate was 47%
Diseases of the Colon & Rectum

The researchers observed that transfusions were associated with previous abdominoperineal resection, correlating strongly with postoperative morbidity.

There were 33 complications in 17 patients, most commonly perineal wound breakdown in 9, and pelvic abscess in 5.

Median hospital stay was 18 days, significantly longer in patients with previous abdominoperineal resection or postoperative morbidity.

The team noted that only postoperative death was from pelvic sepsis.

Resection was complete in 18 patients, with microscopically positive margins in 10, and grossly positive margins in 1.

The researchers identified that the 2-year and 5-year recurrence rates were 47% and 85%, respectively.

Disease-specific survival was 63% and 20%, at 2- and 5 years, respectively.

The team found that less transfusion, complete resection, lack of anterior organ involvement, and absence of cortical bone invasion were associated with better survival on univariate analysis.

Original colorectal cancer stage was not associated with improved survival.

Dr Melton's team commented, “Sacrectomy for rectal cancer is a high-risk procedure that can achieve clear resection margins with low mortality in select patients.”

“This procedure has a low cure rate but may provide local disease control with acceptable morbidity.”

Dis Col Rectum 2006: 49(8): 1099-107
17 August 2006

Go to top of page Email this page Email this page to a colleague

 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Medication nonadherence and health care costs
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Socioeconomic characteristics in diverticular disease
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Heartburn relief in adolescents with GERD
 01 November 2017 
Barriers to hepatitis C treatment
 01 November 2017 
Autoimmune pancreatitis in children
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 31 October 2017 
Endoscopic indices of disease activity for Crohn’s
 31 October 2017 
Follow-up of positive results on fecal blood tests
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's
 26 October 2017 
Conversion to open laparotomy in rectal cancer
 25 October 2017 
Conversion of colonoscopy to sigmoidoscopy
 25 October 2017 
Fecal microbiota transplantation
 25 October 2017 
Rifaximin and survival in hepatic encephalopathy
 24 October 2017 
Eosinophilic esophagitis with swallowed topical corticosteroids
 24 October 2017 
Meta-analysis in nutritiona research
 23 October 2017 
NAFLD-related hepatocellular carcinoma in liver resection
 23 October 2017 
Outcome of hepatic sarcoidosis
 20 October 2017 
Hospital readmissions reduction program
 20 October 2017 
Conversion of planned colonoscopy to sigmoidoscopy
 19 October 2017 
Fecal immunochemical tests in colorectal cancer screening
 19 October 2017 
Current management of chylous ascites

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us